Proteinous amino acids in muscle cytosol of rats' heart, after their treatment with propranolol, pentylenetetrazol or reserpine

Receptors and Channels

Volumn 10, Issue 2, 2004, Pages 83-90

  Gabrys, Janusz ^a   Konecki, Janusz ^a   Głowacka, Maria ^a   Durczok, Katarzyna ^a   Sawczuk, Katarzyna ^a   Brus, Ryszard ^a   Beilaczyc, Grzegorz ^a   Nowak, Przemysław ^a   Shani, Jashovam ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Atrial muscle; Heart muscle; Pentylenetetrazol; Propranolol; Proteinous amino acids; Rats; Reserpine; Total free amino acids; Ventricular muscle

Indexed keywords

AMINO ACID; ARGININE; CYSTEINE; GLUTAMINE; ISOLEUCINE; PENTETRAZOLE; PHENYLALANINE; PROPRANOLOL; RESERPINE; TRYPTOPHAN; TYROSINE;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; GAS LIQUID CHROMATOGRAPHY; HEART ATRIUM MUSCLE; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

AMINO ACIDS; ANIMALS; CYTOSOL; HEART; HEART ATRIA; HEART VENTRICLES; MALE; MYOCARDIUM; PENTYLENETETRAZOLE; PROPRANOLOL; RATS; RATS, WISTAR; RESERPINE;

EID: 3543051097     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: 10.1080/10606820490464343     Document Type: Article

References (44)

1. Anderson, J. L., Rodier, H. E., and Green, L. S. 1983. American Journal of Cardiology 51:1196-1202.
2. Bloom, F. E. 2001. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Tenth edition. Hardman JG, Limbird LE, and Goodman-Gilman A (eds.). McGraw-Hill Medical Publishing Division, pp. 293-320.
3. Baranowska, B. 1989. Post. Nauk Med. (Prog. Med. Sci.) 2:65-69.
4. Bloomstrand, E., Ek, S., and Newsholme, E.A. 1996. Nutrition 12: 485-490.
5. Broten, T. P., Miyashiro, J. K., Moncada, S., and Feigl, E. O. 1992. Am. J. Physiol. 262: H1579-H1584.
6. Cannon, R. O. 1998. Clin. Chem. 44:1809-1819.
7. Chua, B. H. L. 1994. J. Mol. Cell. Cardiol. 26:743-751.
8. Ferro, C.J., and Webb, D.J. 1996. Drugs 51:12-27.
9. Forstermann, U., Gath, I., Schwartz, P., Closs, E. T., and Kleinert, H. 1995. Biochem. Pharmacol. 50:1321-1332.
10. Gabrys, J., Brus, R., Konecki, J., and Shani, J. 2002a. Pharmacol. Rev. Comm. 12:101-108.
11. Gabrys, J., Brus, R., Konecki, J., Stepien, M., Malecki, S., Kuballa, G., and Shaini, J. 2002b. Pharmacol. Rev. Comm. 12:109-118.
12. Gabrys, J., and Konecki, J. 1980. J. Chromatogr. 182:147-154.
13. Gabrys, J., and Konecki, J. 1982. Analytical Biochemistry, Acad Press Inc, pp. 199-206.
14. Gabrys, J., and Konecki, J. 1983. J. Chromatogr. 276:19-27.
15. Gabrys, J., Konecki, J., Shani J., Durczok, A., Bielaczyc, G., Kosteczko, A., Szewczyk, H. and Brus, R. 2003. Receptors Channels 9:301-307.
16. Gabrys, J., Konecki, J., Brus, R., Kiszka, W., and Shaini, J. 2002a. Pharmacol. Rev. Comm. 11:19-25.
17. Gabrys, J., Konecki, J., Shani, J., Brus, R., Harabin-Slowinska, M. 1999a. Pharmacol. Rev. Comm. 10:279-283.
18. Gabrys, J., Shani, J., Brus, R., and Konecki, J. 1999b. Pharmacol. Rev. Comm. 10:233-238.
19. Garcia, R., Lachance, D., Thibault, G., Gutowska, J., and Cantin, M. 1987. In: Biologically Active Atrial Peptide (Brenner BM and Laragh JH, (eds.), Raven Press, NY, pp. 35-40.
20. Hamet, P., and Tremblay, J. 1987. Nephrologie 8:7-12.
21. Hu, J. R., Berninger, K. G., and Lange, R. E. 1988. European Journal of Pharmacology 159:177-178.
22. Huang, C. L., Ives, H.E., and Cogan, M. G. 1987. In: Biologically Active Atrial Peptides (Brenner BM and Lavagh JH, eds.) Raven Press, NY, pp. 266-268.
23. Ito, H. Adachi, S., Tmamori, M., Fujisaki, H., Tanaka, M., Liu, M., Akimoto, H. Marumo, F., and Hiroe, M. 1996. J. Mol. Cell Cardiol. 28: 1271-1277.
24. Jones, L. F., and Brody, M. J. 1992. J. Pharmacol. Exp. Ther. 260:627-631.
25. Katsube, N., Schwartz, D., and Needlmen, P. 1987. Brenner, B. M., and Laragh, J. H. (eds.) Raven Press, NY, pp. 27-34.
26. Kondo, K., Mitchell, J. A., de Nucci, G., and Vane, J. R. 1989. Br. J. Pharmacol. 98:630-636.
27. Lowenstein, C. J., Dienerman, J. L., and Snyder, S. H. 1994. Ann. Int. Med. 120:227-237.
28. Maguire, J. J., and Davenport A. P. 2002. Br. J. Pharmacol. 137:579-588.
29. Malinski, T. 1998. Pol. J. Pharmacol. 50:387-391.
30. Malinski, T. 1999. 7th Symp on the "Endothelium as a target for pharmacotherapy" Jagiellonian Med. Res Cent, Krakow, July 8-10th, Poland (lecture).
31. Moncada, S., and Higgs, A. 1993. N. Engl. J. Med. 329:2002-2012.
32. Moncada, S., Palmer, R. M. J., and Higgs, E. A. 1989. Biochem. Pharmacol. 38:1709-1715.
33. Mullane, K. M., Salomon, J. A., and Kreamer, R. 1987. Federation Procedings 46, 2422-2433.
34. Munger, K. A., Sugiura, M., Takahashi, K., Inagmi, T., and Badr, K. F. 1991. Am. Soc. Nephrol. 1:1278-1283.
35. Murray, R. K., Granner, D. K., Mayes, P. A., and Rodwell, V. W. 1993. Harper's Biochemistry. Prentice Hall Internat Publ. Inc., Los Altos, CA.
36. Rubanyi, G. M., and Vanhoutte, P.M. 1985. J. Physiol. 34:45-56.
37. Shultz-Knappe, P., Herbst, F., Hack, D., Pipkorn, R., and Forsmann, W.G. 1988. Klinische Wochenschrift 66: 752-756.
38. Tanaka, M., Ito, H., Adachi, S., Akimoto, H., Nishikawa, T., Sasajima, T., Marumo, F., and Hiroe, M. 1994. Cir. Res. 75:426-433.
39. Uretzky, G., Vinograd, I., Freud, H., Yaroslavsky, E., Apelbaum, Y. J., and Borman, J. B., 1984. J. Am. Clin. Chem. 3:608 (abstract.)
40. Vane, J. R., and Botting, R. M. 1993. J. Physiol. Pharmacol. 44(Suppl 2):5-36.
41. Yamada, Y., Ishihara, T., Fujiwara, M., Tomato, S., Seki, I., and Oshawa, N. 1993. Jap. Circ. J. 57:272-282.
42. Yanagisawa, M., and Masaki, J. 1989. Trends Pharmacol. Sci. 10:374-378.
43. Young, L. H., McNulty, P. H., Morgan, C., Deckelbaum, L. I., Zaret, B. L., and Baret, E. J. 1991. J. Clin. Investi. 87:554-560.
44. Zhu, Y., Yang, H. T., and Endoh, M. 1997. Eur. J. Pharmacol. 32:195-199.